"my thoughts are that a nasdaq listing might be the trigger as they like a higher share price than a few cents. The way they are going with a US office etc that would be sooner rather than later in my view."
Maybe the thought was for a US listing, but maybe put the timeframe back a bit from that hence the departure of Doug Huey. If the political decision of MSB FDA approval is anything to go by, maybe a delay is a good thing under the current political climate. I know for trials etc we need to be over there, and phase 3 trials have to be US based I believe, but we are a bit from that position as yet.
In the mean time, loving the steep green slope!
PYC Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)